Sage Therapeutics, Inc. (SAGE) - Stock Prices, Stock Peers & Analysis

Home
SAGE

Company Name	Sage Therapeutics, Inc.
Symbol	SAGE
Currency	USD
Price	6.32
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	386,615,256
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	5.64 - 28.26
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Barry E. Greene
Website	https://www.sagerx.com

An error occurred while fetching data.

About Sage Therapeutics, Inc.

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase